- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02223546
Circadian Macular Volume Changes in the Choroid (CVdi)
Pilotstudy: Diurnal Changes in Choroidal Volume
Study Overview
Status
Conditions
Detailed Description
All patients undergo enhanced depth imaging (EDI) by the Spectralis SD-OCT device (Heidelberg Spectralis HRA2, Heidelberg Engineering, Heidelberg, Germany). SD-OCT measurements will be performed in both eyes after pupil dilation.
Scanning Protocol: This studies choroidal volume measurement protocol has been previously published. In short, 31 high resolution B-scans centered at the fovea will be obtained by a single investigator. To optimize image quality each B-scan will be averaged from at least 25 individual scans using the build in eye tracking software (TrueTrack, Heidelberg Engineering, Heidelberg, Germany). Scan length will be set to 9.3mm and spacing to 240µm, resulting in a 30x25 degree area around the fovea.
Each individual will undergo SD-OCT measurement every 3 hours within a 24 hour timeframe (at 0, 3, 6, 9 12, 15, 18, and 21 o'clock; 8 times total). Additionally, automated blood pressure measurement and Goldmann applanation tonometry will be performed every 3 hours. Subject will be instructed to sleep in erect position from 21 to 6 o'clock, and will be awoken for examination at 0 and 3.
OCT Analysis: Two retinal specialists will manually adjust the segmentation lines for automated choroidal volume calculation by the devices build in software. Choroidal thickness is defined as the layer between the outer boarder of the retinal pigment epithelium (RPE) and the hyper reflective layer behind the large vessels of the choroid (chorio-scleral interface). The devices Software thus generates a three-dimensional choroidal thickness map, divided according to the Early Treatment Diabetic Retinopathy Study (EDTRS) grid. In addition to this, subfoveal choroidal thickness will be measured manually using the SD-OCTs integrated caliper tool, drawing a perpendicular line to the RPE within the aforementioned bounds.
This is considered a pilot study, so explorative data analysis will be performed.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Styria
-
Graz, Styria, Austria, 8036
- Department of Ophthalmology, Medical University of Graz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age 18-65, signed informed consent form,
Exclusion Criteria:
- any ocular pathology, including history of ocular surgery or trauma, use of ocular medication, elevated intraocular pressure (IOP), or significant vitreous floaters. Further exclusion criteria were current use of any systemic medications, history of cardio-vascular disease, diabetes mellitus, or hypertension
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
healthy subject
healthy subject, every 3 hour measurement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Macular Choroidal Volume
Time Frame: daily average out of measurements every 3 hours within a 24 hour timeframe
|
macular choroidal volume in the central 6mm
|
daily average out of measurements every 3 hours within a 24 hour timeframe
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Subfoveal Choroidal Thickness
Time Frame: daily average out of measurements every 3 hours within a 24 hour timeframe
|
daily average out of measurements every 3 hours within a 24 hour timeframe
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Ocular Perfusion Pressure
Time Frame: every 3 hours within a 24 hour timeframe
|
mean arterial pressure (MAP) is defined as DBP + 1/3(SBP - DBP); mean ocular perfusion pressure results from 2/3(MAP - IOP).
|
every 3 hours within a 24 hour timeframe
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gerald Seidel, MD, Medical University of Graz
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CVdi
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Choroid Physiology
-
Brigham and Women's HospitalActive, not recruitingPhysiologyUnited States
-
University Hospital, GrenobleCompleted
-
University of CopenhagenRigshospitalet, DenmarkUnknown
-
Sunnybrook Health Sciences CentreNot yet recruitingNormal Physiology
-
National Institute of Neurological Disorders and...National Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingNormal PhysiologyUnited States
-
The University of Hong KongRecruiting
-
National Institute of Mental Health (NIMH)RecruitingNormal PhysiologyUnited States
-
National Eye Institute (NEI)Recruiting
-
National Institute of Mental Health (NIMH)Recruiting
-
National Institute on Aging (NIA)RecruitingNormal PhysiologyUnited States